Advertisement

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy.

04:52 EDT 20th May 2013 | BioPortfolio

Summary of "Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy."

No Summary Available

Affiliation

Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI, USA, devans@mcw.edu.

Journal Details

This article was published in the following journal.

Name: Annals of surgical oncology
ISSN: 1534-4681
Pages:

Links

Medical and Biotech [MESH] Definitions

Glomus Jugulare Tumor

A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. (From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1603-4)

Neoadjuvant Therapy

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Karnofsky Performance Status

A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.

Pancreatic Neoplasms

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Pancreatic Stellate Cells

Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.

PubMed Articles [ 29171 Associated PubMed Articles listed on BioPortfolio]

Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer.

BACKGROUND: Patients with borderline resectable pancreatic ductal adenocarcinoma (PDA) represent a high-risk group of patients due to tumor or patient-related characteristics. The optimal management o...

Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.

BACKGROUND: Borderline resectable pancreatic cancer (BRPC) appears to be most frequently related to a positive surgical margin and has a poor prognosis after resection. However, few reports are availa...

Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer.

BACKGROUND: Margin-negative pancreatectomy provides only chance to cure pancreatic cancer. However, borderline resectable pancreatic cancer (BRPCa) has the risk of incomplete pal...

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer.

BACKGROUND: Pancreatic adenocarcinoma impinging the portal and/or superior mesenteric vein (PV-SMV) is classified as borderline resectable, and preoperative chemoradiation is recommended to increase t...

Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of "Borderline Resectable Disease"?

INTRODUCTION: Current National Comprehensive Cancer Network guidelines recommend neoadjuvant therapy for borderline resectable pancreatic adenocarcinoma to increase the likelihood of achieving R0 rese...

Clinical Trials [ 4759 Associated Clinical Trials listed on BioPortfolio]

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma

The purpose of this study is to determine which multimodality therapy strategy (hepatectomy following transcatheter hepatic arterial chemoembolization or hepatectomy followed by transcathe...

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

The goal of this study is to determine the effect of chemotherapy on decreasing the size of unresectable pancreas cancer thereby allowing it to be surgically removed. In addition, this stu...

Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT

This study is being conducted to find out what effects (good and bad) that a combination of treatment with chemotherapy, radiation therapy and surgery has on you and your pancreatic cance...

Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer

To determine the feasibility and toxicity of neoadjuvant hypofractioned radiotherapy concurrently with weekly gemcitabine and an EGFR tyrosine-kinase inhibitor (OSI-774, Tarceva) in the tr...

Surgery in Treating Patients With Resectable Pancreatic Neoplasms

RATIONALE: Surgery may be an effective way to treat pancreatic neoplasms. PURPOSE: This clinical trial is studying how well surgery works in treating patients with resectable pancreatic n...

Search BioPortfolio:
Advertisement
Advertisement